Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001012975-11-000265
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-20 14:56:56
Reporting Period:
2011-09-16
Filing Date:
2011-09-20
Filing Date Changed:
2011-09-20
Accepted Time:
2011-09-20 15:56:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1375151 Zogenix Inc. ZGNX Pharmaceutical Preparations (2834) 205300780
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1166285 Michael Steinmetz C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1249153 Dennis Henner C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1252522 Nicholas Galakatos C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1252523 Robert Liptak C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1252525 Kurt Wheeler C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
Yes No Yes No
1431403 Nicholas Simon C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1431441 Clarus Ventures I, Llc C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1431445 Clarus Lifesciences I, L.p. C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
1505590 Clarus Ventures I Management, L.p. C/o Clarus Ventures, Llc
101 Main Street, Suite 1210
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-16 3,500,000 $2.00 9,482,439 No 4 P Indirect By Fund
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Fund
Footnotes
  1. Securities held of record by Clarus Lifesciences I, L.P. (the "Fund"). Clarus Ventures I Management, L.P. (the "GPLP"), as the sole general partner of the Fund, may be deemed to beneficially own certain of the shares held of record by the Fund. The GPLP disclaims beneficial ownership of all shares held of record by the Fund in which the GPLP does not have an actual pecuniary interest. Clarus Ventures I, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by the Fund. Each of Messrs. Galakatos, Henner, Liptak, Simon, Steinmetz and Wheeler, as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by the Fund. Each of the GPLLC and Messrs. Galakatos, Henner, Liptak, Simon, Steinmetz and Wheeler disclaims beneficial ownership of all shares held of record by the Fund in which he does not have an actual pecuniary interest.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!